Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanqi Lei

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Biomacromolecules|May 23, 2024
Paclitaxel Overload Supramolecular Oxidative Stress Nanoamplifier with a CDK12 Inhibitor for Enhanced Cancer TherapyHao Zhang, Chengyuan Xing, Binyuan Yan, et al.
Frontiers in Oncology|December 17, 2020
Revealing Prognostic Value of Skeletal-Related Parameters in Metastatic Castration-Resistant Prostate Cancer on Overall Survival: A Systematic Review and Meta-Analysis of Randomized Controlled TrialTongyu Tong, Hanqi Lei, Yupeng Guan, et al.
Journal of Health, Population, and Nutrition|May 29, 2025
A cross-sectional study examining the relationship between the advanced lung cancer inflammation index and prostate cancerMengjun Huang, Qiliang Teng, Dong Ning, et al.
Acta Biomaterialia|July 20, 2023
Tumor acidity-activatable macromolecule autophagy inhibitor and immune checkpoint blockade for robust treatment of prostate cancerYiyao Wang, Hanqi Lei, Binyuan Yan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 14, 2024
ROS-driven supramolecular nanoparticles exhibiting efficient drug delivery for chemo/Chemodynamic combination therapy for Cancer treatmentHuikun Chen, Chengyuan Xing, Hanqi Lei, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 9, 2025
Nop2/Sun domain family member 5 contributes to tumorigenic properties in prostate cancer by engaging the PI3K-AKT pathway and tumor-associated macrophagesMengjun Huang, Hailin Zou, Yufan Liang, et al.
Frontiers in Cell and Developmental Biology|January 10, 2022
DNA Methylation Data-Based Classification and Identification of Prognostic Signature of Children With Wilms TumorFucai Tang, Zeguang Lu, Hanqi Lei, et al.
Current Urology|February 26, 2026
Causal relationships between plasma metabolites and prostate cancer: A Mendelian randomization study exploring immune and inflammatory mediatorsMengjun Huang, Dong Ning, Tongyu Tong, et al.
Advanced Healthcare Materials|October 19, 2023
Multimodal Nanoplatform with ROS Amplification to Overcome Multidrug Resistance in Prostate Cancer via Targeting P-Glycoprotein and FerroptosisYupeng Guan, Hanqi Lei, Chengyuan Xing, et al.
British Journal of Cancer|July 12, 2024
An 18-gene signature of recurrence-associated endothelial cells predicts tumor progression and castration resistance in prostate cancerBing-Biao Lin, Qingqing Huang, Binyuan Yan, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Biomacromolecules|May 23, 2024
Paclitaxel Overload Supramolecular Oxidative Stress Nanoamplifier with a CDK12 Inhibitor for Enhanced Cancer TherapyHao Zhang, Chengyuan Xing, Binyuan Yan, et al.
Frontiers in Oncology|December 17, 2020
Revealing Prognostic Value of Skeletal-Related Parameters in Metastatic Castration-Resistant Prostate Cancer on Overall Survival: A Systematic Review and Meta-Analysis of Randomized Controlled TrialTongyu Tong, Hanqi Lei, Yupeng Guan, et al.
Journal of Health, Population, and Nutrition|May 29, 2025
A cross-sectional study examining the relationship between the advanced lung cancer inflammation index and prostate cancerMengjun Huang, Qiliang Teng, Dong Ning, et al.
Acta Biomaterialia|July 20, 2023
Tumor acidity-activatable macromolecule autophagy inhibitor and immune checkpoint blockade for robust treatment of prostate cancerYiyao Wang, Hanqi Lei, Binyuan Yan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 14, 2024
ROS-driven supramolecular nanoparticles exhibiting efficient drug delivery for chemo/Chemodynamic combination therapy for Cancer treatmentHuikun Chen, Chengyuan Xing, Hanqi Lei, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 9, 2025
Nop2/Sun domain family member 5 contributes to tumorigenic properties in prostate cancer by engaging the PI3K-AKT pathway and tumor-associated macrophagesMengjun Huang, Hailin Zou, Yufan Liang, et al.
Frontiers in Cell and Developmental Biology|January 10, 2022
DNA Methylation Data-Based Classification and Identification of Prognostic Signature of Children With Wilms TumorFucai Tang, Zeguang Lu, Hanqi Lei, et al.
Current Urology|February 26, 2026
Causal relationships between plasma metabolites and prostate cancer: A Mendelian randomization study exploring immune and inflammatory mediatorsMengjun Huang, Dong Ning, Tongyu Tong, et al.
Advanced Healthcare Materials|October 19, 2023
Multimodal Nanoplatform with ROS Amplification to Overcome Multidrug Resistance in Prostate Cancer via Targeting P-Glycoprotein and FerroptosisYupeng Guan, Hanqi Lei, Chengyuan Xing, et al.
British Journal of Cancer|July 12, 2024
An 18-gene signature of recurrence-associated endothelial cells predicts tumor progression and castration resistance in prostate cancerBing-Biao Lin, Qingqing Huang, Binyuan Yan, et al.
Pageof 4